KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to ...

The company is seeking to raise additional funding. Genomind, area Acme parent partner to up awareness of genetic tes Montco firm introduces its latest genetic mental health tool Montco firm ...

KING OF PRUSSIA, PA--(Marketwired - December 10, 2015) - The largest audience to date will soon learn how personalized medicine for brain health is making a difference for patients. "Innovations," an ...

KING OF PRUSSIA, PA--(Marketwired - September 12, 2016) - Genomind (www.genomind.com), a personalized medicine company advancing mental healthcare through genetic testing, will present an educational ...

(BPT) - If you or a family member have sought care from a mental health professional, or are considering seeking help for depression, anxiety, ADHD or other conditions, you want the best treatment ...

King of Prussia-based mental health company Genomind recently expanded its partnership with Acme markets, making its genetic testing service available to patients in all 37 Acme pharmacies across ...

A King of Prussia, Pa., personalized medicine company that has developed a genetic test to help clinicians make more informed treatment decisions for patients with depression has raised another $3.5 ...

KING OF PRUSSIA, PA--(Marketwired - July 18, 2016) - Attention-deficit/hyperactivity disorder (ADHD) affects approximately 11 percent of children 4-17 years of age ...

KING OF PRUSSIA, PA--(Marketwired - February 08, 2017) - Genomind, a personalized medicine company advancing mental healthcare through genetic testing, has completed an $11 million financing with its ...

KING OF PRUSSIA, PA--(Marketwired - December 10, 2015) - The largest audience to date will soon learn how personalized medicine for brain health is making a difference for patients. "Innovations," an ...